EVOLVING TRENDS AND FUTURE PROSPECTS OF ADR MONITORING AND REPORTING: A LITERATURE REVIEW
DOI:
https://doi.org/10.22159/ajpcr.2016.v9i5.12725Abstract
Objective: Owing to the importance of safe use of medicines, adverse drug reaction (ADR) monitoring has become a fundamental component to
be performed along with other health-care services. Pharmacist being drug experts are in good position to provide professional assistance for ADR
management. The aim of this study is to summarize research findings from developed and developing countries as well as from Pakistan regarding
evolving trends and future prospects of ADR monitoring and reporting by pharmacists. Methods: A total of 49 studies were reviewed regarding trends of
ADR monitoring using different search engines including google scholar, pubmed and science direct. Results: The review highlighted that there is need
to identify the barriers and gaps to further enhance the effectiveness of current ADR monitoring practices. Conclusion: Strong legislation is required in
Pakistan to develop and implement an effective ADR monitoring program to reinforce the conception of effective pharmacovigilance system in Pakistan.
Keywords: Adverse drug reactions, Reporting, Pharmacist, Pharmacovigilance, Pakistan.
Downloads
References
Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLoS One 2009;4(2):e4439.
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004 3;329(7456):15-9.
Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care 2003;15 Suppl 1:i49-59.
Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): A meta-analysis of observational studies. Pharm World Sci 2002;24(2):46-54.
WHO. The Safety of Medicines in Public Health Programmes: Pharmacovigilance, an Essential Tool. Geneva: WHO; 2006.
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47(3):533-43.
Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF. Pharmacists versus nonpharmacists in adverse drug event detection: A meta-analysis and systematic review. Am J Health Syst Pharm 2007;64(8):842-9.
Emerson A, Martin RM, Tomlin M, Mann RD. Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group. Pharmacoepidemiol Drug Saf 2001;10(2):95-103.
Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: A systematic review. Arch Intern Med 2006;166(9):955-64.
Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006;166(5):565-71.
Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 2003;29(5):691-8.
Rabbur RS, Emmerton L. An introduction to adverse drug reaction reporting systems in different countries. Int J Pharm Pract 2005;13(1):91-100.
Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: A case-control study in Portugal. Drug Saf 2006;29(4):331-40.
Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Influence of attitudes on pharmacists’ intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol 2011;72(1):143-52.
Ting KN, Stratton-Powell DM, Anderson C. Community pharmacists’ views on adverse drug reactions reporting in Malaysia: A pilot study. Pharm World Sci 2010;32:339-42.
Gavaza P, Bui B. Pharmacy students’ attitudes toward reporting serious adverse drug events. Am J Pharm Educ 2012;76(10):194.
Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharm 1995;29(4):365-9.
Green CF, Raval D, Proudlove C, Randall C. Community pharmacists’ attitudes to adverse drug reaction reporting. Int J Pharm Pract 1999;7(2):92-9.
Ashcroft DM, Morecroft C, Parker D, Noyce PR. Likelihood of reporting adverse events in community pharmacy: An experimental study. Qual Saf Health Care 2006;15(1):48-52.
Van Groothest AM, Berg LT. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract 2002;10:267-72.
Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother 1994;28:1400-3.
Qassim S, Metwaly Z, Shamsain M, Al Hariri Y. Reporting Adverse Drug Reactions: Evaluation of knowledge, attitude and practice among community pharmacists in UAE. Age 2014;22(30):31-40.
Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001;51:81-6.
Palaian S, Mishra P, Shankar PR, Dubey AK, Bista D, Almeida R. Safety monitoring of drugs – Where do we stand? Kathmandu Univ Med J (KUMJ) 2006;4:119-27.
Yadav S. Status of adverse drug reaction monitoring and pharmacovigilance in selected countries. Indian J Pharmacol 2008;40 Suppl 1:S4-9.
Zhang L, Wong LY, He Y, Wong IC. Pharmacovigilance in China: Current situation, successes and challenges. Drug Saf 2014;37:765-70.
Palaian S, Ibrahim MI, Mishra P. Health professionals’ knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharm Pract (Granada) 2011;9:228-35.
Abdel-Latif MM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J 2015;23(2):154-61.
Sivadasan S, Yuong YN, Woan CN, Siew CA, Nazeri AA, Ravichandran V, et al. Knowledge and perception towards pharmacovigilance and adverse drug reaction reporting among medicine and pharmacy students. World J Pharm PharmSci 2014;3(3):1652-76.
Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharm Drug Saf 2010;19:217-22.
Upadhyaya HB, Vora MB, Nagar JG, Patel PB. Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of tertiary care Hospital in Gujarat. J Adv Pharm Technol Res 2015;6(1):29.
Amrita P, Roomi M. Scenario of pharmacovigilance and ADR reporting among pharmacists in Delhi. Indian J Pharm Pract 2011;4(4):29-38.
Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study. Perspect Clin Res 2013;4:204-10.
Khan TM. Community pharmacists’ knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia. Ther Adv Drug Saf 2013;4(2):45-51.
Bawazir SA. Attitude of community pharmacists in Saudi Arabia towards adverse drug reaction reporting. Saudi Pharm J 2006;14(1):75-83.
Mahmoud MA, Alswaida Y, Alshammari T, Khan TM, Alrasheedy A, Hassali MA, et al. Community pharmacists’ knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharm J 2014;22(5):411-8.
Al-Hazmi NN, Naylor I. A study of community pharmacists’ awareness
and contributions to adverse drug reactions (ADRs) reporting systems in the Makkah, Kingdom of Saudi Arabia (KSA). J Clin Trials 2013;3127. Doi:10.4172/2167-0870.1000127.
Elkalmi RM, Hassali MA, Ibrahim MI, Jamshed SQ, Al-Lela OQ. Community pharmacists’ attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: A quantitative insight. J Patient Saf 2014;10(2):81-7.
Swathy G, Dhivya PS, Waseem MD, Susmitha M, Narayana RR, Prasad B. An assessment of community pharmacist attitude towards professional practice and knowledge of adr in South India. IJPT 2013; 4(4):236-41.
Prakasam A, Nidamanuri A, Kumar S. Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India. Pharm Pract (Granada) 2012;10:222-6.
Hailu W, Bhagavathula AS, Admassie E, Patel I, Khan TM. Knowledge, attitude and practices towards adverse drug reaction reporting in Gondar, Ethiopia. J Pharm Health Serv Res 2014;6(2):111. Doi:10.1111/jphs.12065.
Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci 2008;30(5):556-62.
Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci 2009;31:183-7.
Afifi S, Maharloui N, Peymani P, Namazi S, Gharaei AG, Jahani P, et al. Adverse drug reactions reporting: Pharmacists’ knowledge, attitude and practice in Shiraz, Iran. Int J Risk Saf Med 2014;26:139-45.
Suyagh M, Farah D, Farha RA. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm J 2014;3:147-153.
Pakistan DR. 2012-13 10, May, 2015. Available from: http://www.dra.gov.pk/gop/index.php?q=aHR0cDovLzE5Mi4xNjguNzAuMTM2L2RyYXAv.
Association PP. Pakistan Pharmaceutical Industry. 2008 10, May, 2015. Available from: http://www.ppma.org.pk/PPMAIndustry.aspx.
Mustafa G, Rasheed S, Khan MT. Adverse drug reaction reporting system at different hospitals of lahore - An evaluation and patient out-come analysis. J App Pharm.2013; 4(1): 713-719.
Shakeel S, Iffat W, Anjum F, Bushra R, Ibrahim S, Shafiq S. Emerging need of pharmacovigilance: Perspectives of future pharmacist in Pakistan. Int J 2014;5(2):966-9.
Mahmood KT, Tahir FA, Haq IU. Pharmacovigilance - A need for best patient care in Pakistan. A review. J Pharm Sci Res 2011;3(11):1566-84.
Azhar S, Hassali MA, Ibrahim MM. Perceptions of hospital pharmacist’s role in Pakistan’s healthcare system: A cross-sectional survey. Trop J Pharm Res 2011;10(1):2.
Hussain A, Ibrahim MI. Medication counselling and dispensing practices at community pharmacies: A comparative cross sectional study from Pakistan. Int J Clin Pharm 2011;33(5):859-67.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
